February 5, 2020 / 10:19 PM / in 17 days

Drug research firm PPD prices IPO at top end of target

NEW YORK, Feb 5 (Reuters) - Drug research firm PPD Inc on Wednesday priced its initial public offering (IPO) at $27 per share, according to a person familiar with the matter, at the high end of its target range.

The IPO valued North Carolina-based PPD at $9.16 billion. The company had aimed to sell 60 million shares at a target price range of $24-$27 per share.

Representatives for PPD did not immediately respond to a request for comment. (Reporting by Joshua Franklin in New York Editing by Chris Reese)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below